Abstract
BackgroundDermatomyositis (DM) is an immune-mediated idiopathic inflammatory myopathy (IIM). Two subsets of autoantibodies have been identified in patients with IIM. The first includes myositis-specific antibodies (MSA) such as anti-Jo-1, anti-TIF-1...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
